Ascelia Pharma AB   Report issue

For profit Phase 3
Founded: Malmö Sweden (2000)

Organization Overview

First Clinical Trial
2019
NCT04119843
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Ascelia Pharma AB